Download PDF
Fortschr Neurol Psychiatr 2009; 77(6): 353-364
DOI: 10.1055/s-0028-1109130
Fort- und Weiterbildung

© Georg Thieme Verlag KG Stuttgart · New York

Diagnostik und Therapie von Schlafstörungen

Diagnosis and Treatment of Sleep DisordersK. Spiegelhalder1 , D. Riemann1
  • 1Abteilung für Psychiatrie und Psychotherapie, Universitätsklinikum Freiburg
Further Information

Publication History

Publication Date:
01 April 2009 (online)

    Permissions and Reprints

Weiterbildungsziele

In diesem Beitrag sollen folgende Weiterbildungsziele zur nicht organischen Insomnie vermittelt werden:

Prävalenz, klinische und ökonomische Bedeutsamkeit, ein ätiologisches Modell, Diagnostik und Differenzialdiagnostik, Studienlage zur Effektivität psychotherapeutischer Behandlung, Studienlage zur Effektivität pharmakologischer Behandlung, vergleichende Effektivität psychotherapeutischer und pharmakologischer Behandlung.

Literatur

  • 1 American Academy of Sleep Medicine .The International Classification of Sleep Disorders. Westchester; IL 2005 2nd edition
    Google Scholar
  • 2 Ohayon M. Epidemiological study on insomnia in the general population.  Sleep. 1996;  19 7-15
    Google Scholar
  • 3 Zhang B, Wing Y K. Sex differences in insomnia: a meta-analysis.  Sleep. 2006;  29 85-93
    Google Scholar
  • 4 NIH. National Institutes of health state of the science conference statement: Manifestations and management of chronic insomnia in adults.  Sleep. 2005;  28 1049-1057
    Google Scholar
  • 5 Morin C. Insomnia. New York; Guilford Press 1993
    Google Scholar
  • 6 Morin C M, Culbert J P, Schwartz S M. Nonpharmacological interventions for insomnia: a meta-analysis of treatment efficacy.  Am J Psychiat. 1994;  151 1172-1180
    Google Scholar
  • 7 Murtagh D RR, Greenwood K M. Identifying effective pychological treatments for insomnia: a meta-analysis.  J Consult Clin Psych. 1993;  63 79-89
    Google Scholar
  • 8 Montgomery P, Dennis J. A systematic review of non-pharmacological therapies for sleep problems in later life.  Sleep Med Rev. 2004;  8 47-62
    Google Scholar
  • 9 Pallesen S, Nordhus I H, Kvale G. Nonpharmacological interventions for insomnia in older adults: a meta-analysis of treatment efficacy.  Psychotherapy. 1998;  35 472-481
    Google Scholar
  • 10 Irwin M R, Cole J C, Nicassio P M. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55 + years of age.  Health Psychol. 2006;  25 3-14
    Google Scholar
  • 11 Nowell P D, Mazumdar S, Buysse D J. et al . Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy.  JAMA. 1997;  278 2170-2177
    Google Scholar
  • 12 Holbrook A M, Crowther R, Lotter A. et al . Meta-analysis of benzodiazepine use in the treatment of insomnia.  CMAJ. 2000;  162 225-233
    Google Scholar
  • 13 Dündar Y, Dodd S, Strobl J. et al . Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis.  Human Psychopharmacology. 2004;  19 305-322
    Google Scholar
  • 14 Glass J, Lanctot K L, Herrmann N. et al . Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits.  BMJ. 2005;  331 1169
    Google Scholar
  • 15 Krystal A D, Walsh J K, Laska E. et al . Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.  Sleep. 2003;  26 793-799
    Google Scholar
  • 16 Walsh J K, Erman M, Erwin C W. et al . Subjective hypnotic efficacy of trazodone and zolpidem in DSM III-R primary insomnia.  Human Psychopharmacology. 1998;  13 191-198
    Google Scholar
  • 17 Hajak G, Rodenbeck A, Voderholzer U. et al . Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study.  J Clin Psychiatry. 2001;  62 453-463
    Google Scholar
  • 18 Riemann D, Voderholzer U, Cohrs S. et al . Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.  Pharmacopsychiatry. 2002;  35 165-174
    Google Scholar
  • 19 Buscemi N, Vandermeer B, Hooton N. et al . The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis.  J Gen Intern Med. 2005;  20 1151-1158
    Google Scholar
  • 20 Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials.  Sleep Med. 2000;  1 91-99
    Google Scholar
  • 21 McClusky H Y, Milby J B, Switzer P K. et al . Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia.  Am J Psychiat. 1991;  148 121-126
    Google Scholar
  • 22 Morin C M, Colecchi C, Stone J. et al . Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial.  JAMA. 1999;  281 991-999
    Google Scholar
  • 23 Jacobs G D, Pace-Schott E F, Stickgold R. et al . Cognitive behavior therapy and pharmacotherapy for insomnia: a randomized controlled trial and direct comparison.  Arch Intern Med. 2004;  164 1888-1896
    Google Scholar
  • 24 Sivertsen B, Omvik S, Pallesen S. et al . Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.  JAMA. 2006;  295 2851-2858
    Google Scholar
  • 25 Smith M T, Perlis M L, Park A. et al . Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia.  Am J Psychiat. 2002;  159 5-11
    Google Scholar

Dipl.-Psych. Kai Spiegelhalder

Abteilung für Psychiatrie und Psychotherapie Universitätsklinikum Freiburg

Hauptstraße 5

79104 Freiburg

Email: Kai.Spiegelhalder@uniklinik-freiburg.de

      >